| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/22/1993 | EP0561525A1 Process for the expression of herpes simplex virus type 1 glycoprotein E and methods of use |
| 09/22/1993 | EP0561427A1 Monoclonal antibodies to new factor VIII coagulant polypeptides |
| 09/22/1993 | EP0561183A1 Anti-ganglioside monoclonal antibody, its preparation and use as a tumour therapeutic agent |
| 09/22/1993 | EP0561034A2 Direct molecular cloning of a modified eukaryotic cytoplasmic DNA virus genome |
| 09/22/1993 | EP0560969A1 Subunit vaccine for neisseria meningitidis infections and corresponding purified subunits |
| 09/22/1993 | EP0560947A1 Tri- and tetra-valent monospecific antigen-binding proteins |
| 09/22/1993 | EP0560776A1 The gene encoding equine herpesvirus type 1 glycoprotein d, its gene product, antibodies and their uses |
| 09/22/1993 | EP0440740B1 Radiotherapeutic immunoconjugates labeled with iodine-125 |
| 09/22/1993 | EP0355125B1 Process for integrated oncological admission examination and cancer therapy |
| 09/21/1993 | US5246851 Neisseria diagnosis and binding |
| 09/21/1993 | US5246844 Detection of Lyme disease |
| 09/21/1993 | US5246831 Feline infectious peritonitis virus test utilizing monoclonal idiotypic and anti-idiotypic antibodies |
| 09/21/1993 | US5246707 Sustained release delivery of water-soluble bio-molecules and drugs using phospholipid-coated microcrystals, microdroplets and high-concentration liposomes |
| 09/21/1993 | US5246691 Antitumor |
| 09/21/1993 | US5245896 Quick-change tool holder with center height adjustment mechanism |
| 09/21/1993 | CA1322342C Molecular cloning and clones of human b lymphotropic virus (hblv) |
| 09/21/1993 | CA1322341C Method for the preparation of antibody-fragment conjugates |
| 09/21/1993 | CA1322333C Immunological adjuvants for polysaccharide vaccines |
| 09/19/1993 | CA2090303A1 Process for the expression of herpes simplex virus type 1 glycoprotein 1 and methods of use |
| 09/18/1993 | WO1993019053A1 Depsipeptide derivative, production thereof and use thereof |
| 09/16/1993 | WO1993018165A1 Microorganisms having attenuated invasiveness |
| 09/16/1993 | WO1993018163A2 Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria |
| 09/16/1993 | WO1993018161A1 Receptor complexes with b29 (ig-beta or ig-gamma) and their uses |
| 09/16/1993 | WO1993018160A1 Anti-viral fusion peptides |
| 09/16/1993 | WO1993018152A1 Mn gene and protein |
| 09/16/1993 | WO1993018150A1 Helicobacter pylori proteins useful for vaccines and diagnostics |
| 09/16/1993 | WO1993018143A1 Dna encoding taurine and gaba transporters and uses thereof |
| 09/16/1993 | WO1993018055A2 Peptides stimulating cytotoxic lymphocytes respone to hiv-1 gp160 |
| 09/16/1993 | WO1993018054A2 Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
| 09/16/1993 | WO1993018047A1 Nucleic acid sequences coding for or complementary to nucleic acid sequences coding for interleukin 9 receptor |
| 09/16/1993 | WO1993017715A1 Diagnostic and/or therapeutic agents, targeted to neovascular endothelial cells |
| 09/16/1993 | WO1993017712A2 Conjugates formed from heat shock proteins and oligo- or polysaccharides |
| 09/16/1993 | WO1993017707A1 In vivo binding pair pretargeting |
| 09/16/1993 | WO1993017706A1 Genetic vaccine for immunodeficiency viruses |
| 09/16/1993 | WO1993017705A1 Selectively deglycosylated human immunodeficiency virus type 1 envelope vaccines |
| 09/16/1993 | WO1993017703A1 Methods and compositions for the modulation of host immune response to allergens |
| 09/16/1993 | WO1993017700A1 Immune-enhancing agent for therapeutic use in immunocompromised hosts |
| 09/16/1993 | WO1993017699A1 Lymphocyte activity regulation by hla peptides |
| 09/16/1993 | WO1993017698A1 Use of interleukin-10 to suppress graft-vs.-host disease |
| 09/16/1993 | WO1993017108A3 Analogous peptides of the internal image of a viral protein |
| 09/16/1993 | WO1993016087A3 Amadori reaction compounds and products, process for their manufacture, and their use |
| 09/16/1993 | CA2452130A1 Methods and compositions for targeting the vasculature of solid tumors |
| 09/16/1993 | CA2383007A1 Helicobacter pylori proteins useful for vaccines and diagnostics |
| 09/16/1993 | CA2131995A1 Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria |
| 09/16/1993 | CA2131909A1 Selectively deglycosylated human immunodeficiency virus type i envelope vaccines |
| 09/16/1993 | CA2131898A1 Methods and compositions for the modulation of host immune response to allergens |
| 09/16/1993 | CA2131524A1 Use of interleukin-10 to suppress graft-vs.-host disease |
| 09/16/1993 | CA2131444A1 Dna encoding taurine and gaba transporters and uses thereof |
| 09/16/1993 | CA2131369A1 Microorganisms having attenuated invasiveness |
| 09/16/1993 | CA2131299A1 Lymphocyte activity regulation by hla peptides |
| 09/16/1993 | CA2131150A1 Receptor complexes with b29 (ig-beta or ig-gamma) and their uses |
| 09/15/1993 | EP0560409A2 Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation |
| 09/15/1993 | EP0559770A1 Cell stress transcriptional factors |
| 09/15/1993 | EP0494904B1 Device for oral administration of an active principle for preventive treatment of caries in babies |
| 09/15/1993 | CN1022113C Protein and its production method |
| 09/14/1993 | US5245014 Method for isolating factors viii from plasma by gel filtration chromatography under group separation conditions |
| 09/14/1993 | US5245010 Polypeptide of herpes simplex virus vmw 65 protein |
| 09/14/1993 | US5244792 Preparation of vaccines |
| 09/14/1993 | US5244663 Therapeutic method against allergy |
| 09/14/1993 | US5244657 Genetic detoxification of pertussis toxin |
| 09/14/1993 | CA2092674A1 Double transfectants of mhc genes as cellular vaccines for immuno-prevention of tumor metastasis |
| 09/14/1993 | CA1322168C Process for the remission of the symptoms associated with aids |
| 09/12/1993 | WO1993024632A1 Hybrid siv/hiv-1 viral vectors and monkey model for aids |
| 09/12/1993 | CA2135618A1 Vectors expressing hybrid viruses, methods of use and novel assays |
| 09/10/1993 | CA2091195A1 Poultry color-coded inactivated vaccines |
| 09/08/1993 | EP0559234A1 Monoclonal antibodies specific for an epitope in the B chain of platelet-derived growth factor and their use in affinity chromatography |
| 09/08/1993 | EP0558681A1 Treatment for tissue ulceration |
| 09/08/1993 | EP0558631A1 Recombinant avirulent salmonella antifertility vaccines |
| 09/08/1993 | EP0505353B1 Fast printer with a particle trap in the paper channel |
| 09/08/1993 | EP0307434B1 Altered antibodies |
| 09/07/1993 | US5243071 2-alkylidene-aminoguanidines and methods of use therefor |
| 09/07/1993 | US5243030 Conjugates of a synthetic peptide for diagnosis and prevention of influenza virus infection |
| 09/07/1993 | US5242829 Recombinant pseudorabies virus |
| 09/07/1993 | US5242824 Monoclonal antibody to human carcinomas |
| 09/07/1993 | US5242823 Cloning of the 38kd Mycoplasma hyorhinis regression-associated antigen |
| 09/07/1993 | US5242820 Pathogenic mycoplasma |
| 09/07/1993 | US5242813 Mouse monoclonal antibodies specific for normal primate tissue, malignant human cultural cell lines human tumors |
| 09/07/1993 | US5242691 Purified milk product from animal maintained in hyperimmunized state |
| 09/07/1993 | US5242686 Culture and deactivation |
| 09/06/1993 | CA2090957A1 Anti-tumor method and anti-tumor agent |
| 09/05/1993 | CA2107558A1 In vivo binding pair pretargeting |
| 09/05/1993 | CA2090295A1 Process for the expression of herpes simplex virus type 1 glycoprotein e and methods of use |
| 09/04/1993 | WO1993017702A1 Oral vaccine |
| 09/04/1993 | CA2131442A1 Oral vaccine |
| 09/02/1993 | WO1993017118A2 Defective packaging non-oncoviral vectors based on mpmv and hiv |
| 09/02/1993 | WO1993017117A1 Heterologous gene expression in lactococcus, and the expression products therefrom |
| 09/02/1993 | WO1993017115A2 Dysentery vaccine stimulating an immune response against shigatoxin, plasmids and host strains for it |
| 09/02/1993 | WO1993017113A1 RECOMBINANT β-LACTAMASE USABLE AS CARRIER MOLECULE FOR THE PREPARATION OF IMMUNOGENIC COMPOSITIONS |
| 09/02/1993 | WO1993017111A1 Hepatitis c virus peptides |
| 09/02/1993 | WO1993017110A2 A recombinant hepatitis c virus polypeptide |
| 09/02/1993 | WO1993017109A1 Ibv spike protein (2) |
| 09/02/1993 | WO1993017108A2 Analogous peptides of the internal image of a viral protein |
| 09/02/1993 | WO1993017107A1 Improvements in or relating to malaria vaccine |
| 09/02/1993 | WO1993017106A1 Cloning and expression of humanized monoclonal antibodies against human interleukin-4 |
| 09/02/1993 | WO1993017105A1 Altered antibodies, products and processes relating thereto |
| 09/02/1993 | WO1993017044A1 Directed human immune globulin for the prevention and treatment of staphylococcal infections |
| 09/02/1993 | WO1993017041A1 Car receptors and related molecules and methods |
| 09/02/1993 | WO1993017033A1 Inhibition of cell adhesion by chemically-defined oligosaccharides, their derivatives, mimetics, and antibodies directed thereto |
| 09/02/1993 | WO1993017031A2 Nucleic acids encoding dystrophin-associated proteins |
| 09/02/1993 | WO1993016728A1 Improved vaccin against brucella abortus |